RxDoctor Payments Data

Daniel Redziniak, MD

Sports Medicine · Annapolis, MDNPI 1942403514

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (38.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Smith+Nephew at 52.9% of the total. Reporting peaked in 2019 at $1,422 and has fallen 87.3% since, to $180 in 2025.

$3,285in general payments, 2019–2025

Across 24 payments — averaging $136.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$2K
  • Supreme Orthopedic Systems, LLC$1K
  • Vericel Corporation$255
  • Native Surgical, LLC$46
  • Baxter Healthcare$25
  • Johnson & Johnson$22
$255,531in research payments, 2019–2025

Across 34 payments — averaging $7515.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$256K

What the payments were for

  • Travel & lodging$79824%
  • Food & beverage$1,26639%
  • Education$1,22137%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew17$1,737
Supreme Orthopedic Systems, LLC1$1,200
Vericel Corporation3$255
Native Surgical, LLC1$46
Baxter Healthcare1$25
Johnson & Johnson1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,285 in reported general payments places this provider in the 60th percentile of 111 sports medicine providers in Maryland.

See all sports medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$82,291
Medicare patients
206
Services billed
802

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium14$196
Ibuprofen26$145
Tramadol Hcl14$18

Paid to pharmacies, not to this prescriber.

Other sports medicine in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →